![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 30, 22961-22968, July 28, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry and Molecular Biology, Southern
Illinois University, Carbondale, Illinois 62901-4413
Received for publication, May 16, 2000
Digestion of scallop muscle membrane fractions
with trypsin led to release of soluble polypeptides derived from the
large cytoplasmic domain of a Na+-Ca2+
exchanger. In the presence of 1 mM Ca2+, the
major product was a peptide of ~37 kDa, with an N terminus corresponding to residue 401 of the NCX1 exchanger. In the presence of
10 mM EGTA, ~16- and ~19-kDa peptides were the major
products. Polyclonal rabbit IgG raised against the 37-kDa peptide also
bound to the 16- and 19-kDa soluble tryptic peptides and to a
105-110-kDa polypeptide in the undigested membrane preparation. The
16-kDa fragment corresponded to the N-terminal part of the 37-kDa
peptide. The conformation of the precursor polypeptide chain in the
region of the C terminus of the 16-kDa tryptic peptide was thus altered by the binding of Ca2+. Phosphorylation of the parent
membranes with the catalytic subunit of protein kinase A and
[ The Na+-Ca2+ exchangers of the plasma
membrane catalyze a secondary active transport process dependent on the
Na+ electrochemical gradient generated by the
Na+,K+-ATPase and play a major role in cellular
Ca2+ homeostasis in many tissues (1). Three
Na+-Ca2+ exchanger proteins (NCX1, NCX2,
and NCX3) have been described in vertebrates (2-5). The molecular
biology of the Na+-Ca2+ exchanger
(Calx) from Drosophila has been described (6, 7), and an exchanger from squid has been reported (8). An electroneutral Na+-Ca2+ antiporter has also been found in
mitochondria, where it may be involved in modulating matrix
Ca2+ in response to changes in cytoplasmic Ca2+
concentration (9, 10).
The protein moieties of the plasma membrane
Na+-Ca2+ exchanger proteins are close in
overall size (~103-106 kDa) (4, 11) to the
SERCA1-type Ca2+-ATPase pumps, which
have a molecular mass of ~110 kDa (12). In the case of NCX1,
a signal sequence of 32 amino acid residues at the N terminus of the
protein is removed post-translationally (13-15). From the N terminus,
structure prediction algorithms suggest that five transmembrane
segments lead to a large cytoplasmic, followed by four C-terminal
transmembrane helices (14-16). Two internal stretches of the f
loop, Phe407(375)-Asp478(443) and
Thr538(506)-Tyr613(581),2
show similarity to one another, and are termed the The isolated cardiac exchanger shows three bands on silver-stained
SDS gels: a glycosylated 120-kDa species corresponding to the
native exchanger, a glycosylated 160-kDa polypeptide representing oxidized exchanger, and an unglycosylated polypeptide of 70 kDa, which
arises by proteolysis of the 120-kDa protein at the
Asp289(257)-Gly or Asp303(270)-Gly bonds in
the large cytoplasmic domain (11, 21-23). Digestion of the exchanger
with chymotrypsin leads to a loss of regulatory function, probably
through proteolysis localized in the cytoplasmic f loop (4).
The study of the protein chemistry of the
Na+-Ca2+ exchanger has been hampered by its low
abundance; even in cardiac muscle, the NCX1 exchanger represents only
0.1-0.2% (w/w) of the sarcolemmal membrane protein (24). The
mitochondrial exchanger is present at 0.4 µg/mg total protein (10).
Thus, silver staining has often been necessary to detect the protein on
SDS gels (21).
In the past, a number of studies of the Ca-ATPase from the
cross-striated adductor muscle of the deep sea scallop have used a
deoxycholate-extracted membrane fraction enriched in fragmented SR (25-28). In the course of examining the effect of
trypsin on this preparation, it was observed that soluble polypeptides
were released by the action of the protease in sufficient amounts for them to be detected by conventional staining of SDS gels with Coomassie
Blue. Sequencing of these tryptic fragments showed that they were not
derived from the Ca-ATPase but instead possessed N termini identifying
them as overlapping stretches of polypeptide originating in the large
cytoplasmic domain (f loop) of a Na+-Ca2+
exchanger. Because this region of the Na+-Ca2+
exchanger is crucial for its regulation through physiological mechanisms and because it may represent a possible target for pharmacological intervention, the polypeptides were further investigated.
Deep sea scallops (Placopecten magellanicus) were
obtained from the Marine Biology Laboratory (Woods Hole, MA).
Preparation of Native Membranes Enriched in Fragmented
Sarcoplasmic Reticulum--
This was carried out essentially as
described previously (25-30). Total scallop muscle membranes were
separated into fractions enriched in SL (B1 fraction) and
SR (B2 fraction) by layering the crude total membranes,
suspended in 0.32 M sucrose, 0.1 M KCl, 1 mM CaCl2, 20 mM MOPS-Na, pH 7.0, onto a discontinuous gradient comprised of a layer of 0.8 M
sucrose on 1.3 M sucrose, both in 0.1 M KCl, 1 mM CaCl2, 20 mM MOPS-Na, pH 7.0 (29, 30). The SL-enriched fraction (B1) banded at the
0.32-0.8 M sucrose interface, and the SR-enriched fraction
(B2) banded at the 0.8-1.3 M interface (25,
29, 30). The B2 fraction was collected.
Preparation of Membranes Enriched in Sarcolemma--
The
B1 fraction was prepared as described above (25, 29,
30).
Preparation of Deoxycholate-extracted Scallop Membrane
Fractions--
This was carried out when necessary with both the
SL-rich (B1) and SR-rich (B2) fractions, as
described previously (25).
Preparation of Soluble Fragments from Tryptic
Digests--
Membranes were typically suspended at 5-10 mg
ml Concentration of Soluble Peptides for Use in
SDS-PAGE--
Sodium deoxycholate was added to the high speed
supernatant from the tryptic digest to a final concentration of 0.025%
(w/v), followed by trichloroacetic acid to a final concentration of 6% (w/v). The trichloroacetic acid also served to completely inactivate the trypsin. After incubation on ice for 15 min, the preparation was
centrifuged at 16,000 × g for 1/2 h, the
supernatant was carefully removed, and the pellet was washed with 200 µl of diethyl ether. After drying, the pellet was dissolved in
Tricine or Laemmli sample denaturation buffer.
Gel Electrophoresis--
Discontinuous SDS-PAGE was carried out
with glycine or Tricine as the trailing anion (31, 32). Sodium
thioglycholate (0.1 mM) was present in the sample
denaturation medium and added to the cathode buffer to scavenge the gel
ahead of the peptides for free radicals and oxidants.
N-terminal Sequencing--
The proteolytic fragments were
separated by SDS-PAGE, and the gels were electroblotted onto
Immobilon-PSQ polyvinylidene difluoride membrane (Millipore) in a
medium of 10% (v/v) MeOH, 10 mM CAPS-Na, pH 11 at 4 °C.
After lightly staining with Coomassie Blue, the bands of interest were
cut out and sent to the Protein Chemistry Core of the University of Florida.
Phosphorylation of the Membranes with Protein Kinase A--
The
DOC-extracted B2 membrane fraction (1 mg) was incubated
with 50 units of the catalytic subunit of PKA in a medium of 0.27 M sucrose, 80 mM KCl, 5 mM EGTA,
0.08 mM CaCl2, 29 mM NaF, 8.3 mM MgCl2, 20 mM MOPS-Na, pH 7.0 containing 0.1 mM [ Production of Rabbit Polyclonal Antibody against the ~37-kDa
Soluble Tryptic Fragment--
The soluble tryptic fraction formed in
the presence of Ca2+ was run on a Tricine SDS gel. The gel
was then lightly stained with Coomassie Brilliant Blue, and the
~37-kDa band was cut out with a razor blade. The gel slice was
homogenized in PBS (0.15 M NaCl, 10 mM sodium
phosphate, pH 7.2) and Freund's complete adjuvant before injection
into New Zealand White rabbits. Booster injections were made every
third week using Freund's incomplete adjuvant. Partial purification of
antibody from serum was by ammonium sulfate fractionation, followed by
DEAE-Sephacel anion exchange chromatography to separate IgG and IgM
(33).
Western Blotting--
SDS gels were first blotted onto
polyvinylidene difluoride (Immobilon PSQ), as in the procedure for
N-terminal sequencing (see above). Nonspecific binding was blocked with
5% w/v nonfat milk in PBS-T (0.1 M NaCl, O.1% v/v
Tween-20, 0.1 M NaPi, pH 7.4) for 1 h at
room temperature. The blots were washed twice quickly in PBS-T,
followed by one wash for 15 min and two washes for 5 min in PBS-T. The
blots were incubated in rabbit anti-37-kDa antibody diluted 1:1000 with
5% (w/v) nonfat dried milk, 0.1% v/v Tween-20 in PBS-for 1 h at
room temperature with gentle agitation. The blots were then washed as
before with PBS-T. The blots were then incubated for 1 h in goat
anti-rabbit IgG secondary antibody conjugated with horseradish
peroxidase (Amersham Pharmacia Biotech) that had been diluted
1:1,500 in 5% (w/v) dried milk in PBS-T. After washing again with
PBS-T, the blots were incubated with the ECL luminol system (Amersham
Pharmacia Biotech).
Protein Concentration--
This was by the bicinchoninic acid
method (34).
The starting materials for the work reported here were membrane
fractions prepared from the cross-striated part of the adductor muscle
of the deep sea scallop. One of these (the B2 fraction; see
"Experimental Procedures") is enriched in fragmented SR but still
contaminated by membranes derived from the SL (25, 29). This fraction
can be extracted with low (nonsolubilizing) concentrations of DOC to
remove peripheral membrane proteins and other contaminants (25). On SDS
gels of the DOC-extracted B2 fraction, ~90% of the
Coomassie Blue-staining material has a mobility corresponding to a
molecular mass of 105-115 kDa (Fig. 1
and Ref. 25), consistent with the size of the Ca-ATPase (25, 35, 36).
The second scallop muscle fraction (B1), which was used
later in the studies, is enriched in SL (29).
Tryptic digests of the DOC-extracted scallop muscle B2
membrane fraction were examined for soluble peptide fragments released by the action of the protease. It was found that a polypeptide of ~37
kDa was the major soluble species formed in the presence of 1 mM Ca2+ (Fig. 2),
although smaller amounts of soluble ~16- and ~19-kDa peptides were
sometimes also present. In the presence of 10 mM EGTA, the
pattern of the products was reversed, so that the ~37-kDa fragment
was either absent or present in much smaller amounts, and the two
smaller polypeptides were the main soluble products. The relative
proportions of ~16- and ~19-kDa peptides varied; sometimes the two
species were present in approximately the same amounts, whereas in
other digests one form predominated. This may mean that the 16- and
19-kDa fragments are susceptible to further proteolysis; in contrast,
the ~37-kDa peptide was relatively resistant to the further action of
trypsin. All three soluble peptides could be clearly visualized on the
gels with standard Coomassie Blue stain. Occasionally, larger soluble
polypeptides of ~60 and 40 kDa were observed.
A Ca2+-dependent Tryptic Cleavage Site
and a Protein Kinase A Phosphorylation Site Are Present in the
Ca2+ Regulatory Domain of Scallop Muscle
Na+-Ca2+ Exchanger*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP led to incorporation of 32P into
the 16- and 37-kDa soluble fragments. A site may exist within the
Ca2+ regulatory domain of a scallop muscle
Na+-Ca2+ exchanger that mediates direct
modulation of secondary Ca2+ regulation by cAMP.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1 and
-2 repeats (6). A high affinity Ca2+ binding region
(Kd, 0.1-3 µM) is present in the
large cytoplasmic domain (17-20). This binds Ca2+
cooperatively and provides regulation of the exchanger through the
I2 mechanism, in which increased levels of cytoplasmic
Ca2+ activate the enzyme (19). The regulatory
Ca2+ binding region involves the
-1 repeat and extends
through the variable region between the two
repeats to the
beginning of
-2 (18). Two acidic triads, one at the C terminus of
-1 (Asp478(446)-Asp-Asp) and one in the variable region,
(Asp530(498)-Asp-Asp), just N-terminal to
-2, are
important components of this high affinity Ca2+ binding
site (18).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 in standard media of 20% (v/v) ethylene
glycol (Pierce), 0.15 M KCl, 1 mM CaCl2 or 10 mM EGTA-Na, 50 mM MOPS-Na, pH 7.0. Digestions were at room temperature for
10-15 min. with N-tosyl-L-phenylalanyl chloromethyl ketone-treated trypsin (Sigma, dissolved in 1 mM HCl at 12,000 units/mg) added in a 1:30 (w/w) ratio to
total membrane protein (giving 400 units of activity/mg total membrane
protein). Digestions were terminated by addition of
4-(2-aminoethyl)benzenesulfonyl fluoride (Calbiochem) to a final
concentration of 20 mM, followed by transfer of the sample
to ice. The samples were centrifuged at 16,000 × g for
1/2 h at 4 °C in an Eppendorf microcentrifuge. The
supernatant was collected and recentrifuged for 1 h at
105 × g in a Beckman TL100 bench top ultracentrifuge at
4 °C to remove traces of contaminating membranes.
-32P]ATP (500 dpm
pmol
1) for 2 min at 30 °C. The membranes were
sedimented at 16,000 × g and washed free of unbound
radioactivity. The phosphorylated membranes were then divided into two
parts, one of which was resuspended in 20% (v/v) ethylene glycol, 0.4 M KCl, 1 mM CaCl2, 50 mM MOPS-Na, pH 7.0, while the other was resuspended in 20%
(v/v) ethylene glycol, 0.4 M KCl, 10 mM EGTA,
50 mM MOPS-Na, pH 7.0. Digestion with trypsin was then
carried out as described above. The soluble products were separated
from insoluble (membrane-bound) material and concentrated by the
DOC-trichloroacetic acid procedure described above. The phosphorylated
samples were electrophoresed in the Tricine SDS gel system, and
autoradiography of the dried gel was carried out using Kodak X-Omat film.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
View larger version (15K):
[in a new window]
Fig. 1.
The scallop muscle B2 fraction
after extraction with deoxycholate. The scallop B2
membrane fraction was extracted with DOC as described under
"Experimental Procedures" and electrophoresed in the Laemmli
Tris-glycine system on a 12.5% gel. Approximately 90% of the
Coomassie Blue-stained material on the gel has a size in the
105-115-kDa range. A small amount of a polypeptide of ~28 kDa is
present, probably representing contamination by a component of the SL
that resists DOC extraction (29).

View larger version (88K):
[in a new window]
Fig. 2.
Effect of Ca2+ concentration on
soluble tryptic fragments produced from a deoxycholate-treated scallop
muscle membrane fraction. Digestion of deoxycholate-extracted
scallop muscle membrane B2 was carried out in the presence
of EGTA and Ca2+ as described under "Experimental
Procedures." The soluble peptides formed in the presence of
CaCl2 and EGTA were concentrated by the DOC-trichloroacetic
acid method and electrophoresed in the Tricine SDS-PAGE system. The
bands labeled t in lanes 1 and 2 are
trypsin (molecular mass, 23.8 kDa) and of two its autolyzis products.
Lane 1, soluble peptides formed from 190 µg of total
membrane protein in the presence of EGTA. Lane 2, soluble
peptides formed from 190 µg of total membrane protein in the presence
of Ca2+. Lane 3, markers.
The precursor polypeptide for the soluble peptides had to be very close in size to the scallop SERCA (molecular mass, 110 kDa), because only material of 105-115 kDa was present in sufficient amounts in the starting preparation to account for the amounts of soluble peptides formed (Fig. 1 and Ref. 25). There are usually only small and variable traces of other integral protein membrane components on Coomassie Blue stained SDS gels of the B2 fraction after DOC extraction, the most significant of these being a 28-kDa protein associated with the SL (25, 29). The latter peptide is too small to be the precursor of the 37-kDa soluble tryptic fragment and in any case is present only at low levels.
The results of N-terminal sequencing of the soluble fragments are shown
in Table I, where the data have been
aligned to show the apparent relationships between the peptides and
some sodium-calcium exchangers. The ~37-kDa peptide produced in the
presence of Ca2+ and the ~16-kDa polypeptide formed by
digestion in the absence of Ca2+ had the same N-terminal
sequence. Comparison of this N-terminal sequence with known sequences
using the EMBL data base (Blitz) indicated that its start corresponded
to residue 401(369) of the NCX1 Na+-Ca2+
exchanger, at the N-terminal end of the
-1 repeat in the large cytoplasmic domain (loop f) (2, 4). A lysyl or arginyl residue must
precede this sequence for the 37- and 16-kDa fragments to be produced
by the action of trypsin. There was no significant similarity to any
part of the scallop Ca-ATPase polypeptide chain (36). Assuming an
average residue mass of 110 Da, the ~16-kDa fragment was
approximately 145 residues long and was likely to correspond closely to
the segment of loop f in NCX1 that starts and ends with the two acidic
triads, Asp478(446)-Asp-Asp at the carboxyl end of
-1
and Asp530(498)-Asp-Asp preceding the
-2 repeat. The
Ca2+-insensitive cleavage site on the scallop precursor
represented by the N terminus of the ~16- and ~37-kDa soluble
fragments will be designated the T1 site. The C terminus of
the ~16-kDa fragment must be located in a stretch of polypeptide
chain inaccessible to trypsin when Ca2+ is bound to the
precursor protein but more susceptible to proteolysis when
Ca2+is unbound. The Ca2+-sensitive proteolytic
cleavage site represented by the C terminus of the ~16-kDa fragment
will be designated the T2 site. Satisfactory N-terminal
sequencing of the ~19-kDa band peptide was not possible, because of
microheterogeneity within that band on SDS gels, but the size of the
fragment is consistent with it representing that part of the 37-kDa
fragment which is C-terminal to the T2 cleavage site. There
is other evidence supporting this conclusion from the immunological and
phosphorylation studies reported below. The tryptic cleavage site
corresponding to the C terminus of the 37-kDa fragment, and possibly
the C terminus of the 19-kDa fragment, will be designated the
T3 site.
|
Polyclonal Antibody against the 37-kDa Soluble Fragment
Cross-reacts with the 16- and 19-kDa Soluble Tryptic Fragments and Also
a 105-110-kDa Polypeptide in the Undigested Membranes--
The
soluble fragments formed in the presence of Ca2+ were
separated on a Tricine SDS gel, and a Western blot was obtained using polyclonal rabbit IgG raised against the ~37-kDa peptide. All three
peptides bound the antibody, indicating common epitopes between the
37-kDa peptide and the 16-kDa peptide and between the 37-kDa peptide
and the 19-kDa peptide (Fig. 3).
|
Western blots of Tricine SDS gels of the undigested DOC extracted
B2 membrane fraction probed with rabbit anti-37 kDa peptide antibody showed heavy labeling of the 105-110 band (Fig.
4), which was of the approximate size
anticipated for a Na+-Ca2+ exchanger. Although
only material in the 105-110-kDa region was detected on the blots with
Coomassie Blue, Western blots showed in addition traces of a ~60-kDa
peptide that bound the antibody. This ~60-kDa membrane-bound fragment
may have represented the segment of the scallop muscle
Na+-Ca2+ exchanger C-terminal to cleavage site
T1, formed by proteolytic damage during the preparation and
DOC extraction of the membranes. This polypeptide would have contained
the stretch of peptide chain containing the epitopes of the 37-kDa
tryptic fragment. (The predicted size for such a fragment, assuming a
mean residue mass of 110 Da and a length of ~1,000 residues for the
scallop exchanger, would be 62-63 kDa.)
|
Thus, sequence comparisons indicated that the soluble tryptic fragments were not derived from the Ca-ATPase but from a Na+-Ca2+ exchanger, and Western blots suggested that the precursor of the soluble peptides was in the expected size range for a Na+-Ca2+ exchanger. The sarcoplasmic reticulum is an internal cytoplasmic cellular membrane and therefore cannot be associated with any secondary active transport process dependent on a Na+ electrochemical gradient. Although the Ca-ATPase must account for most of the material in the 105-115-kDa band on SDS gels of the scallop B2 membrane fraction (25-30), a second, non-Ca-ATPase protein, a Na+-Ca2+ exchanger, is also present. This enzyme not only has a similar size to the Ca-ATPase but also in addition coincidentally happens to resist extraction by low concentrations of DOC, like the Ca-ATPase. In fact, there is evidence that extraction of the membrane with low concentrations of DOC does not remove all of the non-SR material from the preparation. Thus, traces of a ~28-kDa protein associated with the SL remain in the DOC-extracted B2 membrane fraction (Fig. 1 and Refs. 25 and 29). Again, the near UV absorption spectrum (not shown) of the DOC-extracted B2 preparation dissolved in SDS shows that the material contains a trienoic chromophore known to be located in the SL (29). Therefore, some residual structures derived from elements of the SL that contaminate the fragmented SR-enriched B2 fraction (29) may survive the DOC extraction step and provide a plausible location for the Na+-Ca2+ exchanger found in this work.
The Precursor of the Soluble Tryptic Fragments Is Also Present in a
Membrane Fraction Enriched in Sarcolemma--
Because there was a
possibility that the precursor of soluble tryptic fragments was located
in the SL, the B1 scallop muscle membrane fraction enriched
in SL was prepared as described under "Experimental Procedures."
Digestion of the native (non-DOC extracted) B1 membranes
with trypsin yielded only traces of the soluble peptides (Fig.
5, lanes 2 and 3).
However, when the B1 fraction was first extracted with low
concentrations of DOC, according to the protocol used with the
B2 fraction, and then treated with trypsin, the soluble
fragments were formed in substantially larger amounts (Fig. 5,
lanes 4 and 5). As with digestion of the
DOC-extracted B2 fraction, the 37-kDa fragment was the
major soluble product in the presence of Ca2+, whereas the
16- and 19-kDa peptides were the predominant species released by
digestion in the presence of EGTA.
|
The increased yield of the soluble tryptic fragments after treatment of the B1 membrane fraction with DOC was consistent with those peptides originating in the large cytoplasmic domain (f loop) of a Na+-Ca2+ exchanger, if most of the SL vesicles in the initial preparation had a right-side-out orientation. Only after partial disruption of the SL membrane by the low (nonsolubilizing) concentrations of detergent used in the extraction would the loop, located on the internal surface of such vesicles, become accessible to the protease.
The Precursor of the Soluble Tryptic Fragments Is in a Membrane
Domain Insoluble in Nonionic Detergent--
The scallop SL is rich in
cholesterol, whereas the SR has a low cholesterol content (29). Because
cholesterol-rich domains of membranes are resistant to cold nonionic
detergents (37), the DOC-treated B2 fraction was extracted
with the nonionic detergent C12E9 to determine
whether the precursor of the soluble fragments remained with the
insoluble residue. (This procedure is routinely used to prepare
solubilized Ca-ATPase (25, 38).) The material resistant to
C12E9 was washed free of detergent and
solubilized protein and then digested with trypsin in the presence and
absence of Ca2+ in the usual way. This treatment yielded
the soluble tryptic fragments, with larger amounts of the 37-kDa
fragment being formed in the presence of 1 mM
Ca2+, whereas more of the 16- and 19-kDa peptides were
produced in 10 mM EGTA (Fig.
6). This result was consistent with the
precursor of the soluble fragments being an integral membrane protein
in a cholesterol-rich membrane, such as the SL, contaminating the SR-rich B2 fraction. (As discussed below, it is difficult
to completely separate the scallop muscle SR and SL membrane
fractions.)
|
Treatment of Muscle Membranes with cAMP-dependent
Kinase Leads to Phosphorylation of the Soluble Tryptic
Fragments--
Because there have been suggestions that the large
cytoplasmic loop of the Na+-Ca 2+ exchanger
might be a substrate for protein kinase A (cAMP-dependent protein kinase (2-4)), the DOC-extracted B2 scallop muscle
membrane fraction was treated with the catalytic subunit of PKA and
[
-32P]ATP (Experimental Procedures). After
electrophoresis of a sample of the undigested phosphorylated membranes
in the Tricine SDS system, autoradiography of the gel was carried out.
A heavily labeled band was present in the 105-110-kDa region of the
gel, and phosphorylation of a polypeptide of ~60 kDa was also seen (Fig. 7). The Ca-ATPase of the scallop SR
lacks a PKA consensus phosphorylation sequence
(R(R/K)X(S/T)) (36). As with the rabbit SERCA1a enzyme,
self-phosphorylation of the Ca-ATPase using ATP has an absolute
requirement for Ca2+ (27, 28) and so cannot occur under the
conditions of the PKA treatment, which is carried out in the presence
of excess EGTA. Thus, the phosphorylated peptides were likely to
correspond to intact exchanger and the 60-65-kDa membrane-bound
C-terminal proteolytic fragment detected by Western blotting (see
above).
|
The phosphorylated membranes were then digested with trypsin separately
in 1 mM Ca2+ and 10 mM EGTA.
Autoradiography of SDS gels of the soluble peptides in the supernatants
showed that the ~37- and ~16-kDa fragments were heavily
phosphorylated, but the ~19-kDa peptide was unlabeled (Fig.
8).
|
| |
DISCUSSION |
|---|
|
|
|---|
Precise regulation of intracellular Ca2+ levels is critical for the appropriate activation/inactivation of some key cell functions, such as motility and exocytosis. Recently, intracellular Ca2+ has been revealed as a triggering factor for apoptosis (39). Thus, regulation of the channels and transporters determining cell Ca2+ levels is of physiological and pharmacological interest. Sodium-calcium exchange represents one of the most important and widespread mechanisms available to the cell for controlling intracellular Ca2+ concentration. The large cytoplasmic loop of the exchanger is accessible to internal signals reflecting cell status and so has evolved as a regulatory domain mediating the effect of changes in cell Ca2+ concentration on the direction of net Ca2+ movement across the plasma membrane. It is also apparent that external signals may affect the activity of the Na+-Ca2+ exchanger (40). The work reported here suggests that both types of signal may be transduced through the same region of the f loop.
Only material of 105-110 kDa was present in sufficient amounts in the
initial DOC-extracted scallop muscle membrane preparation to act as a
precursor for the soluble tryptic fragments. The origin of the soluble
fragments in a ~110-kDa species was confirmed by Western blots using
rabbit anti-37-kDa peptide IgG. Coincidentally, the precursor is not
only close in size to the scallop SR Ca-ATPase, but in addition, like
the Ca-ATPase, it resists extraction by low concentrations of DOC;
however, unlike the Ca-ATPase it is not solubilized by cold nonionic
detergent. The N-terminal sequence of the 37- and 16-kDa soluble
fragments shows substantial similarity to a segment of the putative f
loop of the well described NCX1 exchanger that is associated with
regulation of the enzyme activity by Ca2+. This region in
the predicted structure for NCX1 has a location compatible with the
presence of a site susceptible to proteolytic enzymes and the
production of water-soluble fragments. Because the precursor is also an
integral membrane protein with an appropriate molecular mass for a
Na+-Ca2+ exchanger, it is likely to represent
an enzyme of that class located in scallop muscle membranes. Such
transporters are ubiquitous in animal cells (41), and both plasma
membrane (sarcolemmal) and mitochondrial
Na+-Ca2+ exchangers must be present in scallop
muscle. The possible overall relationships between the tryptic
fragments and the putative parent molluscan
Na+-Ca2+ exchanger are shown in Fig.
9. Gel shift experiments with fusion proteins containing the regulatory Ca2+-binding site of
NCX1 have indicated that a large conformational change occurs in the
-1-
-2 region when Ca2+ becomes bound (18, 19). The
difference in accessibility to trypsin of the region represented by the
T2 cleavage site on the scallop exchanger between the
Ca2+-bound and Ca2+-free states may be a
reflection of such a refolding of the large cytoplasmic domain of the
exchanger on binding and release of the ligand.
|
The scallop muscle Na+-Ca2+ exchanger reported here is 105-110 kDa in size, close to that of the mitochondrial exchanger (10), but smaller than the ~120 kDa of the glycosylated NCX1 plasma membrane exchanger. This observation might suggest that the precursor of the soluble tryptic fragments reported here is the scallop mitochondrial exchanger; however, oligomycin-sensitive Ca-ATPase and succinic dehydrogenase activities present in the native scallop membrane preparations (42) are removed by DOC extraction, and there is no indication from SDS gels of significant contamination of the DOC-extracted scallop membrane preparation by the F0F1-ATPase (Fig. 1 and Ref. 25). Even in preparations of purified beef heart mitochondria, the Na+-Ca2+ exchanger is present in only small amounts (0.4 µg/mg total protein (24)).
There was direct evidence consistent with a sarcolemmal location for the precursor of the soluble tryptic fragments. Digestion of the DOC-extracted B1 membrane fraction (SL-enriched) with trypsin yielded soluble peptides, with more 37-kDa fragment being released in the presence of Ca2+ and more 19- and 16-kDa material in the presence of EGTA. The fact that treatment of the membranes with deoxycholate before digestion with trypsin greatly increased the amount of soluble fragments released supports an origin for the soluble tryptic fragments in the Ca2+-regulatory binding site region of the large cytoplasmic domain (f loop). Presumably, treatment with low concentrations of DOC renders the SL permeable to trypsin and allows the protease access to the cytoplasmic loop of the exchanger on the interior aspect of the membrane. If most of the native vesicles derived from the SL in the preparation were right-side-out, a large increase in the extent of proteolysis of the cytoplasmic domain of the enzyme would be expected after DOC treatment. In fact, ~70% of the ouabain-inhibitable Na+,K+-ATPase activity of the scallop muscle B1 membrane fraction has to be unmasked by treatment with 0.2% (w/v) saponin.3 Because the large cytoplasmic domain of the Na+,K+-ATPase, which binds the substrate ATP, is located on the inner aspect of the plasma membrane, this finding is consistent with the majority of the native membrane vesicles derived from the scallop SL being right-side-out. The fact that the insoluble residue left after extraction of the membranes with cold nonionic detergent is a good source of the tryptic fragments fits a location for this scallop Na+-Ca2+ exchanger in some perhaps specialized domain of a cholesterol-rich membrane, such as the SL.
The presence of the precursor of the soluble tryptic fragments in both the B1 (SL-enriched) and B2 (SR-enriched) membrane fractions may be due to the difficulty in completely resolving the scallop SL and SR membrane fractions (29). This problem arises, at least in part, because in the scallop cross-striated adductor muscle, which has no transverse tubules, SR cisternae analogous to the terminal cisternae of vertebrate skeletal muscle lie directly beneath the SL (43). The two types of membrane are connected morphologically by foot-type structures resembling those associated with the ryanodine receptor complex seen in the triads of vertebrate muscle. Ryanodine-type Ca2+ release channels have been observed in preparations of scallop muscle membranes (44). Possibly, the patches of SL overlying the junctions fulfill some of the functions of the transverse tubules of vertebrate cross-striated muscle. Disruption of the scallop muscle on homogenization may leave pieces of these domains of the SL attached to fragments of the SR cisternae. The resulting structures may collect in the B1 or B2 fraction, depending on the relative proportions of lipid-rich SL and protein-rich SR that remain associated. Thus, the scallop Na+-Ca2+ exchanger may be localized in SL domains associated with underlying cisternae of the SR. The presence of the scallop muscle exchanger in membranes resistant to cold nonionic detergent and its possible relation to underlying elements of the SR are consistent with previous studies of amphibian smooth muscle (45). That work demonstrated functional and structural linkages among the Na+-Ca2+ exchanger, Na+-K+ pump, and the Ca2+ pump of the SR and showed that the exchanger was concentrated in caveolae of smooth muscle sarcolemma that were in close proximity to the SR. Caveolae are rich in cholesterol and insoluble in cold nonionic detergent (46).
ATP increases the affinity of the transport sites for Ca2+
and Na+ on the cardiac NCX1 exchanger and the squid giant
axon (47). There is evidence that phosphoryl transfer is important for
the action of ATP in the squid axon and that a
Ca2+-dependent protein kinase may be involved
in the effect (48). However, in the case of cardiac muscle, protein
kinases do not appear to be implicated (49), and a mechanism involving
PIP2 interaction with the XIP region may be present (50,
51). Nevertheless, a potential phosphorylation site for
cAMP-dependent PKA and calcium calmodulin-stimulated
protein kinase is present in the f loop of NCX1, at
Ser389(357) in the R385(352)KAVS sequence, just
N-terminal to the Ca2+ regulatory region (2). A possible
substrate site for these kinases is present at Thr113 in
NCX3, on the putative intracellular loop between transmembrane helices
1 and 2 (4). Possible sites for phosphorylation by PKA and protein
kinase C exist at Thr262 and Thr267 in the XIP
regions of NCX2 and NCX3 (3, 5). All three vertebrate exchangers
possess a potential site for tyrosine kinase phosphorylation in the
-2 repeat, and there may be mixed control of the exchangers through
Ca2+ and phosphorylation (4). The site(s) on the scallop
Na+-Ca2+ exchanger phosphorylated by the
catalytic subunit of PKA and detected on the 16- and 37-kDa soluble
tryptic fragments must, of course, be C-terminal to the residue on the
scallop Na+-Ca2+ exchanger equivalent to
residue 401 of NCX1. The 16-kDa peptide, which is derived from the
-1-
-2 stretch of exchanger polypeptide, spans that part of the f
loop containing the Ca2+ regulatory domain. A PKA substrate
site must therefore exist in the Ca2+ regulatory domain of
the scallop Na+-Ca2+ exchanger, and thus there
is a possibility that the Ca2+ regulatory domain in the
large cytoplasmic loop can be directly affected by agonists whose
effects are mediated by the level of cellular cAMP. Western blotting
indicated common epitopes between the 19- and 37-kDa soluble tryptic
peptides. Thus, the complete absence of any phosphorylation of the
19-kDa soluble peptide by PKA and its size suggest that it represents
the segment of the Na+-Ca2+ exchanger lying
between cleavage sites T2 and T3,
i.e. the C-terminal segment of the 37-kDa peptide.
In cardiac muscle, Na+-Ca2+ exchange makes an
extremely important contribution to the relaxation phase of the
contractile cycle (1, 40, 47). In addition to its role in relaxation,
when removal of Ca2+ from the sarcoplasm by the exchanger
is combined with Ca2+ uptake into the SR, it has been
suggested that the Na+-Ca2+ exchanger may also
be involved in the initiation of contraction (52). This would be by
supplementing the Ca2+ influx into cardiac muscle through
L-type Ca2+ channels that is associated with
Ca2+-induced Ca2+ release from the cardiac SR.
The role of the scallop exchanger in the physiology of the scallop
muscle cell remains to be determined. Because scallop muscle Ca-ATPase
lacks both a phospholamban binding site and a PKA phosphorylation
consensus sequence (36), regulation of cell Ca2+ by cAMP
through effects on the pumping rate of the SERCA enzyme appears to be
excluded. However, cAMP may affect Ca2+ levels in the
scallop muscle cell through PKA phosphorylation of the sarcolemmal
Na+-Ca2+ exchanger. The fact that the exchanger
copurifies so closely with the SR Ca-ATPase suggests a relationship
between the two membrane Ca2+ transport systems. In future
studies, structural changes in the protein associated with
Ca2+ binding and phosphorylation will be examined, and the
nature of the possibly specialized cellular structure containing the exchanger will be investigated in detail.
| |
FOOTNOTES |
|---|
* This work was supported by the Illinois Affiliate of the American Heart Association through Grant-in Aid C-04/GS-04.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Open System Div., Information Builders Inc., Two
Penn Plaza, 28th Floor, New York, NY 10121.
§ To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Mail Code 4413, Southern Illinois University, Carbondale, IL 62901-4413. Tel.: 618-453-6469; Fax: 618-453-6440; E-mail: phardwicke@siumed.edu.
Published, JBC Papers in Press, May 16, 2000, DOI 10.1074/jbc.M001743200
2 Residue positions are given first for the coded protein sequence and then in parentheses for the processed polypeptide.
3 P. M. D. Hardwicke, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: SERCA, Sarco(endo)plasmic veticulum calcium ATPase; SR, sarcoplasmic reticulum; C12E9, nonaethylene glycol dodecyl ether; DOC, deoxycholate; PKA, protein kinase A (cAMP-dependent kinase); SL, sarcolemma; MOPS, 3-(N-morpholino)propanesulfonic acid; PAGE, polyacrylamide gel electrophoresis; CAPS, 3-(cyclohexylamino)propanesulfonic acid; Tricine, N-[2-hydroxy-1,1-bis (hydroxymethyl)ethyl]glycine; PBS, phosphate-buffered saline.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Blaustein, M., Goldman, W. F., Fontana, G., Kreuger, B. K., Santiago, E. M., Steele, T. D., Weiss, D. N., and Yarowsky, P. J. (1991) Ann. N. Y. Acad. Sci. 639, 254-274 |
| 2. | Nicoll, D. A., Longoni, S., and Philipson, K. D. (1990) Science 250, 562-564 |
| 3. | Li, Z., Matsuoka, S., Hryshko, L. V., Nicoll, D. A., Bersohn, M. M., Burke, E. P., Lifton, R. P., and Philipson, K. D. (1994) J. Biol. Chem. 269, 17434-17439 |
| 4. | Nicoll, D. A., Quednau, B. D., Qui, Z., Xia, Y.-R., Lusis, A. J., and Philipson, K. D. (1996) J. Biol. Chem. 271, 24914-24921 |
| 5. | Quednau, B. D., Nicoll, D. A., and Philipson, K. D. (1997) Am. J. Physiol. 272, C1250-C1261 |
| 6. | Schwarz, E. M., and Benzer, S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 10249-10254 |
| 7. | Ruknudin, A., Valdiva, C., Kofuji, P., Lederer, W. J., and Schulze, D. H. (1997) Am. J. Physiol. 273, C257-C265 |
| 8. | He, Z., Tong, Q., Quednau, B., Philipson, K. D., and Hilgemann, D. W. (1998) J. Gen. Physiol. 111, 857-873 |
| 9. | Cox, D. A., and Matlib, M. A. (1993) Trends Pharmacol. Sci. 14, 408-413 |
| 10. | Li, W., Shariat-Madar, Z., Powers, M., Sun, X., Lane, R. D., and Garlid, K. D. (1992) J. Biol. Chem. 267, 17983-17989 |
| 11. | Philipson, K. D., Longoni, S., and Ward, R. (1988) Biochim. Biophys. Acta 945, 298-306 |
| 12. | Møller, J. V., Juul, B., and le Maire, M. (1996) Biochim. Biophys. Acta 1286, 1-51 |
| 13. | Durkin, J. T., Ahrens, D. C., Pan, Y.-C., and Reeves, J. P. (1991) Arch. Biochem. Biophys. 290, 369-375 |
| 14. | Hryshko, L., Nicoll, D. A, Weiss, J. N., and Philipson, K. D. (1993) Biochim. Biophys. Acta 1151, 35-42 |
| 15. | Cook, O., Low, W., and Rahamimoff, H. (1998) Biochim. Biophys. Acta 1371, 40-52 |
| 16. | Nicoll, D. A., Ottolia, L., Lu, L., Lu, Y., and Philipson, K. D. (1999) J. Biol. Chem. 274, 910-917 |
| 17. | Matsuoka, S., Nicoll, D. A., Reilly, R. F., Hilgemann, D. W., and Philipson, K. D. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3870-3874 |
| 18. | Levitsky, D. O., Nicoll, D. A., and Philipson, K. D. (1994) J. Biol. Chem. 269, 22847-22852 |
| 19. | Matsuoka, S., Nicoll, D. A., Hryshko, L V., Levitsky, D. O., Weiss, J. N., and Philipson, K. D. (1995) J. Gen. Physiol. 105, 404-420 |
| 20. | Philipson, K. D., Nicoll, D. A., Matsuoka, S., Hryshko, L. V., Levitsky, D. O., and Weiss, J. N. (1996) Ann. N. Y. Acad. Sci. 779, 20-28 |
| 21. | Durkin, J. T., Ahrens, D. C., Aceto, J. F., Condrescu, M., and Reeves, J. P. (1991) Ann. N. Y. Acad. Sci. 639, 189-201 |
| 22. | Santacruz-Toloza, L., Ottolia, M., Nicoll, D. A., and Philipson, K. D. (2000) J. Biol. Chem. 275, 182-188 |
| 23. | Iwata, T., Galli, C., and Carafoli, E. (1995) Cell Calcium 17, 263-269 |
| 24. | Cheon, J., and Reeves, J. P. (1988) J. Biol. Chem. 263, 2309-2315 |
| 25. | Kalabokis, V., and Hardwicke, P. M. D. (1988) J. Biol. Chem. 263, 15184-15188 |
| 26. | Kalabokis, V. N., Bozzola, J. J., Castellani, L., and Hardwicke, P. M. D. (1991) J. Biol. Chem. 266, 22044-22050 |
| 27. | Hardwicke, P. M. D., and Huvos, P. (1989) J. Musc. Res. Cell Motil. 10, 229-244 |
| 28. | Hardwicke, P. M. D., and Bozzola, J. J. (1989) J. Musc. Res. Cell Motil. 10, 245-253 |
| 29. | Hardwicke, P. M. D., Ryan, C., and Kalabokis, V. N. (1999) Biochim. Biophys. Acta 1417, 1-8 |
| 30. | Kalabokis, V. N., and Hardwicke, P. M. D. (1993) Biochim. Biophys. Acta 1147, 35-41 |
| 31. | Laemmli, U. K. (1970) Nature 227, 680-685 |
| 32. | Schägger, H., and von Jagow, G. (1987) Anal. Biochem. 166, 368-379 |
| 33. | Dunbar, B. S., and Schwoebel, E. (1990) Methods Enzymol. 182, 663-670 |
| 34. | Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Anal. Biochem. 150, 76-85 |
| 35. | Castellani, L., Hardwicke, P. M. D., and Vibert, P. (1985) J. Mol. Biol. 185, 579-594 |
| 36. | Shi, X., Chen, M., Huvos, P. E., and Hardwicke, P. M. D. (1998) Comp. Biochem. Physiol. Part B 120, 359-374 |
| 37. | Schroeder, R. J., Ahmed, S. N., Zhu, Y., London, E., and Brown, D. A. (1998) J. Biol. Chem. 273, 1150-1157 |
| 38. | Kalabokis, V. N., Santoro, M. M., and Hardwicke, P. M. D. (1993) Biochemistry 32, 4389-4396 |
| 39. | Wang, H.-G., Pathan, N., Ethell, I. M., Krajewski, S., Yamaguchi, Y., Shibasaki, F., McKeon, F., Bobo, T., Franke, T. F., and Reed, J. C. (1999) Science 284, 339-343 |
| 40. | Reeves, J. P., Condrescu, M., Chernaya, G., and Gardner, J. P. (1994) J. Exp. Biol. 196, 375-388 |
| 41. | Lederer, W., J., He, S., Luo, S., DuBell, W., Kofuji, P., Keval, R., Neubauer, C. F., Ruknudin, A., Cheng, H., Cannell, M. B., Rogers, T. B., and Schulze, D. H. (1996) Ann. N. Y. Acad. Sci. 779, 7-17 |
| 42. | Castellani, L., and Hardwicke, P. M. D. (1983) J. Cell Biol. 97, 557-561 |
| 43. | Nunzi, M. G., and Franzini-Armstrong, C. (1981) J. Ultrastruct. Res. 76, 134-148 |
| 44. | Loesser, K. E., Castellani, L., and Franzini-Armstrong, C. (1992) J. Musc. Res. Cell Motil. 13, 161-173 |
| 45. | Moore, E. D. W., Etter, E. F., Philipson, K. D., Carrington, W. A., Fogarty, K. E., Lifshitz, L. M., and Fay, F. S. (1993) Nature 365, 657-660 |
| 46. | Sargiacomo, M., Sudol, M., Tang, Z., and Lisanti, M. (1993) J. Cell Biol. 122, 789-807 |
| 47. | Philipson, K. D., and Nicoll, D. A. (1993) Int. Rev. Cytol. 137C, 199-227 |
| 48. | DiPolo, R., and Beauge, L. (1994) Am. J. Physiol. 266, C1382-C1391 |
| 49. | Hilgemann, D. W. (1990) Nature 344, 242-245 |
| 50. | Hilgemann, D. W., and Ball, R. (1996) Science 273, 956-959 |
| 51. | He, Z., Feng, S., Tong, Q., Hilgemann, D. W., and Philipson, K. D. (2000) Am. J. Physiol. 278, C661-C666 |
| 52. | Leblanc, N., and Hume, J. R. (1990) Science 248, 372-376 |
This article has been cited by other articles:
![]() |
C. Ryan, D. L. Stokes, M. Chen, Z. Zhang, and P. M. D. Hardwicke Effect of Orthophosphate, Nucleotide Analogues, ADP, and Phosphorylation on the Cytoplasmic Domains of Ca2+-ATPase from Scallop Sarcoplasmic Reticulum J. Biol. Chem., February 13, 2004; 279(7): 5380 - 5386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shigekawa and T. Iwamoto Cardiac Na+-Ca2+ Exchange : Molecular and Pharmacological Aspects Circ. Res., May 11, 2001; 88(9): 864 - 876. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||